2021
Moazami-Goudarzi K, Andréoletti O, Vilotte J L & Béringue V. Review on PRNP genetics and susceptibility to chronic wasting disease of Cervidae. Vet. Res. 2021 Oct; 52(1): e128.
Douet J Y, Huor A, Cassard H, Lugan S, Aron N, Mesic C, Vilette D, Barrio T, Streichenberger N, Perret-Liaudet A, Delisle M B, Péran P, Deslys J P, Comoy E, Vilotte J L, Goudarzi K, Béringue V, Barria M A, Ritchie D L, Ironside J W & Andréoletti O. Prion strains associated with iatrogenic CJD in French and UK human growth hormone recipients. Acta Neuropathol. Commun. 2021 Aug; 9(1): e145.
Martin D, Reine F, Herzog L, Igel-Egalon A, Aron N, Michel C, Moudjou M, Fichet G, Quadrio I, Perret-Liaudet A, Andréoletti O, Rezaei H & Béringue V. Prion potentiation after life-long dormancy in mice devoid of PrP. Brain Commun. 2021 Apr; 3(2): fcab092.
Zhang W, Xiao X, Ding M, Yuan J, Foutz A, Moudjou M, Kitamoto T, Langeveld J P M, Cu L & Zou W Q. Further Characterization of Glycoform-Selective Prions of Variably Protease-Sensitive Prionopathy. Pathog. Basel Switz. 2021 Apr; 10(5): e513.
Bamia A, Sinane M, Naït-Saïdi R, Dhiab J, Keruzoré M, Nguyen P H, Bertho A, Soubigou F, Halliez S, Blondel M, Trollet C, Simonelig M, Friocourt G, Béringue V, Bihel F & Voisset C. Anti-prion Drugs Targeting the Protein Folding Activity of the Ribosome Reduce PABPN1 Aggregation. Neurother. J. Am. Soc. Exp. Neurother. 2021 Apr; 18(2): 1137–1150.
Castille J, Passet B, Makhzami S, Vilotte M, Moazami-Goudarzi K, Truchet S, Daniel-Carlier N, Gaillard A L, Andréoletti O, Vaiman D, Beauvallet C, Vaiman A, Floriot S, Calvel P, Mouillet-Richard S, Duchesne A, Béringue V & Vilotte J L. Co-invalidation of Prnp and Sprn in FVB/N mice affects reproductive performances and highlight complex biological relationship between PrP and Shadoo. Biochem. Biophys. Res. Commun. 2021 Apr; 551: 1–6.
2020
Moudjou M, Castille J, Passet B, Herzog L, Reine F, Vilotte J L, Rezaei H, Béringue V & Igel-Egalon A. Improving the Predictive Value of Prion Inactivation Validation Methods to Minimize the Risks of Iatrogenic Transmission With Medical Instruments. Front. Bioeng. Biotechnol. 2020 Dec; 8: e591024.
Munoz-Montesino C, Larkem D, Barbereau C, Igel-Egalon A, Truchet S, Jacquet E, Nhiri N, Moudjou M, Sizun C, Rezaei H, Béringue V & Dron M. A seven-residue deletion in PrP leads to generation of a spontaneous prion formed from C-terminal C1 fragment of PrP. J. Biol. Chem. 2020 Oct; 295(41): 14025–14039.
Huin C, Cronier S, Guégan P, Béringue V, Rezaei H & Noinville S. Conformation-dependent membrane permeabilization by neurotoxic PrP oligomers: The role of the H2H3 oligomerization domain. Arch. Biochem. Biophys. 2020 Oct; 692: e108517.
Bohl J, Sicard C, Rezaei H, Van der Rest G & Halgand F. Evidence of conformational landscape alteration and macromolecular complex formation in the early stages of in vitro human prion protein oxidation. Arch. Biochem. Biophys. 2020 Sept; 690: e108432.
Lévy E, Jaffrézic F, Laloë D, Rezaei H, Huang M E, Béringue V, Martin D & Vernis L. PiQSARS: A pipeline for quantitative and statistical analyses of ratiometric fluorescent biosensors. MethodsX 2020 Aug; 7: e101034.
Béringue V, Tixador P, Andréoletti O, Reine F, Castille J, Laï T L, Le Dur A, Laisné A, Herzog L, Passet B, Rezaei H, Vilotte J & Laude H. Host prion protein expression levels impact prion tropism for the spleen. PLoS Pathog. 2020 July; 16(7): e1008283.
Igel-Egalon A, Laferrière F, Tixador P, Moudjou M, Herzog L, Reine F, Torres J M, Laude H, Rezaei H & Béringue V. Crossing Species Barriers Relies on Structurally Distinct Prion Assemblies and Their Complementation. Mol. Neurobiol. 2020 June; 57(6): 2572–2587.
Cassard H, Huor A, Espinosa J C, Douet J Y, Lugan S, Aron N, Vilette D, Delisle M B, Marín-Moreno A, Peran P, Beringue V, Torres J M, Ironside J W & Andreoletti O. Prions from Sporadic Creutzfeldt-Jakob Disease Patients Propagate as Strain Mixtures. mBio 2020 June; 11(3): e00393-20.
Passet B, Castille J, Makhzami S, Truchet S, Vaiman A, Floriot S, Moazami-Goudarzi K, Vilotte M, Gaillard A L, Helary L, Bertaud M, Andréoletti O, Vaiman D, Calvel P, Daniel-Carlier N, Moudjou M, Beauvallet C, Benharouga M, Laloé D, Mouillet-Richard S, Duchesne A, Béringue V & Vilotte J L. The Prion-like protein Shadoo is involved in mouse embryonic and mammary development and differentiation. Sci. Rep. 2020 Apr; 10(1): e6765.
La Rosa C, Condorelli M, Compagnini G, Lolicato F, Milardi D, Do T N, Karttunen M, Pannuzzo M, Ramamoorthy A, Fraternali F, Collu F, Rezaei H, Strodel B & Raudino A. Symmetry-breaking transitions in the early steps of protein self-assembly. Eur. Biophys. J. EBJ 2020 March; 49(2): 175–191.
Barrio T, Filali H, Otero A, Sheleby-Elías J, Marín B, Vidal E, Béringue V, Torres J M, Groschup M, Andréoletti O, Badiola J J & Bolea R. Mixtures of prion substrains in natural scrapie cases revealed by ovinised murine models. Sci. Rep. 2020 Mar; 10(1): e5042.
Bélondrade M, Jas-Duval C, Nicot S, Bruyère-Ostells L, Mayran C, Herzog L, Reine F, Torres J M, Fournier-Wirth C, Béringue V. Lehmann S & Bougard D. Correlation between Bioassay and Protein Misfolding Cyclic Amplification for Variant Creutzfeldt-Jakob Disease Decontamination Studies. mSphere 2020 Jan; 5(1): e00649-19.
2019
Doumic M, Fellner K, Mezache M & Rezaei H. A bi-monomeric, nonlinear Becker-Döring-type system to capture oscillatory aggregation kinetics in prion dynamics. J. Theor. Biol. 2019 Nov; 480: 241–261.
Igel-Egalon A, Laferrière F, Moudjou M, Bohl J, Mezache M, Knäpple T, Herzog L, Reine F, Jas-Duval C, Doumic M, Rezaei H & Béringue V. Early stage prion assembly involves two subpopulations with different quaternary structures and a secondary templating pathway. Commun. Biol. 2019 Oct; 2.
Al-Dybiat I, Moudjou M, Martin D, Reine F, Herzog L, Truchet S, Berthon P, Laude H, Rezaei H, Andréoletti O, Béringue V & Sibille P. Prion strain-dependent tropism is maintained between spleen and granuloma and relies on lymphofollicular structures. Sci. Rep. 2019 Oct; 9(1): e14656.
Wang Z, Yuan J, Shen P, Abskharon R, Lang Y, Dang J, Adornato A, Xu L, Chen J, Feng J, Moudjou M, Kitamoto T, Lee H G, Kim Y S, Langeveld J, Appleby B, Ma J, Kong Q, Petersen R B, Zou W Q & Cui L. Correction to: In Vitro Seeding Activity of Glycoform-Deficient Prions from Variably Protease-Sensitive Prionopathy and Familial CJD Associated with PrPV180I Mutation. Mol. Neurobiol. 2019 Aug; 56(8): 5470.
Wang Z, Yuan J, Shen P, Abskharon R, Lang Y, Dang J, Adornato A, Xu L, Chen J, Feng J, Moudjou M, Kitamoto T, Lee H G, Kim Y S, Langeveld J, Appleby B, Ma J, Kong Q, Petersen R B, Zou W Q & Cui L. In Vitro Seeding Activity of Glycoform-Deficient Prions from Variably Protease-Sensitive Prionopathy and Familial CJD Associated with PrPV180I Mutation. Mol. Neurobiol. 2019 Aug; 56(8): 5456–5469.
Van der Rest G, Rezaei H & Halgand F. Transient multimers modulate conformer abundances of prion protein monomer through conformational selection. Sci. Rep. 2019 Aug; 9(1): e12159.
Lévy E, El Banna N, Baïlle D, Heneman-Masurel A, Truchet S, Rezaei H, Huang M-E, Béringue V, Martin D & Vernis L. Causative Links between Protein Aggregation and Oxidative Stress: A Review. Int. J. Mol. Sci. 2019 Aug; 20(16): e3896.
Igel-Egalon A, Bohl J, Moudjou M, Herzog L, Reine F, Rezaei H & Béringue, V. Heterogeneity and Architecture of Pathological Prion Protein Assemblies: Time to Revisit the Molecular Basis of the Prion Replication Process? Viruses 2019 May; 11(5): e429.
Hirsch T Z, Martin-Lannerée S, Reine F, Hernandez-Rapp J, Herzog L, Dron M, Privat N, Passet B, Halliez S, Villa-Diaz A, Lacroux C, Klein V, Haïk S, Andréoletti O, Torres J-M, Vilotte J-L, Béringue V & Mouillet-Richard S. Epigenetic Control of the Notch and Eph Signaling Pathways by the Prion Protein: Implications for Prion Diseases. Mol. Neurobiol. 2019 March; 56(3): 2159–2173.
Torrent J, Martin D, Noinville S, Yin Y, Doumic M, Moudjou M, Béringue V & Rezaei H. Pressure Reveals Unique Conformational Features in Prion Protein Fibril Diversity. Sci. Rep. 2019 Feb; 9(1): e2802.
Marín-Moreno A, Aguilar-Calvo P, Moudjou M, Espinosa J C, Béringue V & Torres J M. Thermostability as a highly dependent prion strain feature. Sci. Rep. 2019 Aug; 9(1): e11396.
Torrent J, Martin D, Igel-Egalon A, Béringue V & Rezaei H. High-Pressure Response of Amyloid Folds. Viruses 2019 Feb; 11(3): e202.
Combet S, Cousin F, Rezaei H & Noinville S. Membrane interaction of off-pathway prion oligomers and lipid-induced on-pathway intermediates during prion conversion: A clue for neurotoxicity. Biochim. Biophys. Acta Biomembr. 2019 Feb; 1861(2), 514–523.
Helal M, Igel-Egalon A, Lakmeche A, Mazzocco P, Perrillat-Mercerot A, Pujo-Menjouet L, Rezaei H & Tine L M. Stability analysis of a steady state of a model describing Alzheimer’s disease and interactions with prion proteins. J. Math. Biol. 2019 Jan; 78(1-2): 57–81.
2018
Collu F, Spiga E, Chakroun N, Rezaei H & Fraternali F. Probing the early stages of prion protein (PrP) aggregation with atomistic molecular dynamics simulations. Chem. Commun. Camb. Engl. 2018 July; 54(57): 8007–8010.
Ragagnin A, Ezpeleta J, Guillemain A, Boudet-Devaud F, Haeberle A M, Demais V, Vidal C, Demuth S, Beringue V, Kellermann O, Schneider B, Grant N J & Bailly Y. Cerebellar compartmentation of prion pathogenesis. Brain Pathol 2018 Mar; 28(2): 240-263.
Igel-Egalon A, Beringue V, Rezaei H & Sibille P. Prion Strains and Transmission Barrier Phenomena. Pathogens 2018 Jan; 7(1): 5.
2017
Privat N, Levavasseur E, Yildirim S, Hannaoui S, Brandel J P, Laplanche J L, Beringue V, Seilhean D & Haik S. Region-specific protein misfolding cyclic amplification reproduces brain tropism of prion strains. J Biol Chem. 2017 Oct 06; 292(40): 16688-16696.
Igel-Egalon A, Moudjou M, Martin D, Busley A, Knapple T, Herzog L, Reine F, Lepejova N, Richard C A, Beringue V & Rezaei H. Reversible unfolding of infectious prion assemblies reveals the existence of an oligomeric elementary brick. PLoS Pathog. 2017 Sep; 13(9): e1006557.
Armiento A, Moireau P, Martin D, Lepejova N, Doumic M & Rezaei H. The mechanism of monomer transfer between two structurally distinct PrP oligomers. PLoS One. 2017; 12(7): e0180538.
Douet J Y, Lacroux C, Aron N, Head M W, Lugan S, Tillier C, Huor A, Cassard H, Arnold M, Beringue V, Ironside J W & Andreoletti O. Distribution and Quantitative Estimates of Variant Creutzfeldt-Jakob Disease Prions in Tissues of Clinical and Asymptomatic Patients. Emerg Infect Dis. 2017 Jun; 23(6): 946-956.
Ragagnin A, Ezpeleta J, Guillemain A, Boudet-Devaud F, Haeberle A M, Demais V, Vidal C, Demuth S, Beringue V, Kellermann O, Schneider B, Grant N J & Bailly Y. Cerebellar compartmentation of prion pathogenesis. Brain Pathol. 2017 Mar 07.
Voisset C, Blondel M, Jones G W, Friocourt G, Stahl G, Chedin S, Beringue V & Gillet R. The double life of the ribosome: When its protein folding activity supports prion propagation. Prion. 2017 Mar 04; 11(2): 89-97.
Martin-Lanneree S, Halliez S, Hirsch T Z, Hernandez-Rapp J, Passet B, Tomkiewicz C, Villa-Diaz A, Torres J M, Launay J M, Beringue V, Vilotte J L & Mouillet-Richard S. The Cellular Prion Protein Controls Notch Signaling in Neural Stem/Progenitor Cells. Stem Cells. 2017 Mar; 35(3): 754-765.
Van der Rest G, Rezaei H & Halgand F. Monitoring Conformational Landscape of Ovine Prion Protein Monomer Using Ion Mobility Coupled to Mass Spectrometry. J Am Soc Mass Spectrom. 2017 Feb; 28(2): 303-314.
Le Dur A, Lai TL, Stinnakre MG, Laisne A, Chenais N, Rakotobe S, Passet B, Reine F, Soulier S, Herzog L, Tilly G, Rezaei H, Beringue V, Vilotte J L & Laude H. Divergent prion strain evolution driven by PrPC expression level in transgenic mice. Nat Commun. 2017 Jan 23; 8: 14170.
Munoz-Montesino C, Sizun C, Moudjou M, Herzog L, Reine F, Igel-Egalon A, Barbereau C, Chapuis J, Ciric D, Laude H, Beringue V, Rezaei H & Dron M. A stretch of residues within the protease-resistant core is not necessary for prion structure and infectivity. Prion. 2017 Jan 02; 11(1): 25-30.
2016
Bougard D, Brandel J P, Belondrade M, Beringue V, Segarra C, Fleury H, Laplanche J L, Mayran C, Nicot S, Green A, Welaratne A, Narbey D, Fournier-Wirth C, Knight R, Will R, Tiberghien P, Haik S & Coste J. Detection of prions in the plasma of presymptomatic and symptomatic patients with variant Creutzfeldt-Jakob disease. Sci Transl Med. 2016 Dec 21; 8(370): 370ra182.
Bernelin-Cottet C, Deloizy C, Stanek O, Barc C, Bouguyon E, Urien C, Boulesteix O, Pezant J, Richard C A, Moudjou M, Da Costa B, Jouneau L, Chevalier C, Leclerc C, Sebo P, Bertho N & Schwartz-Cornil I. A Universal Influenza Vaccine Can Lead to Disease Exacerbation or Viral Control Depending on Delivery Strategies. Front Immunol. 2016 7: 641.
Jaumain E, Quadrio I, Herzog L, Reine F, Rezaei H, Andreoletti O, Laude H, Perret-Liaudet A, Haik S & Beringue V. Absence of Evidence for a Causal Link between Bovine Spongiform Encephalopathy Strain Variant L-BSE and Known Forms of Sporadic Creutzfeldt-Jakob Disease in Human PrP Transgenic Mice. J Virol. 2016 Dec 01; 90(23): 10867-10874.
Munoz-Montesino C, Sizun C, Moudjou M, Herzog L, Reine F, Chapuis J, Ciric D, Igel-Egalon A, Laude H, Beringue V, Rezaei H & Dron M. Generating Bona Fide Mammalian Prions with Internal Deletions. J Virol. 2016 Aug 01; 90(15): 6963-75.
Moudjou M, Chapuis J, Mekrouti M, Reine F, Herzog L, Sibille P, Laude H, Vilette D, Andreoletti O, Rezaei H, Dron M & Beringue V. Glycoform-independent prion conversion by highly efficient, cell-based, protein misfolding cyclic amplification. Sci Rep. 2016 Jul 07; 6: 29116.
Armiento A, Doumic M, Moireau P & Rezaei H. Estimation from moments measurements for amyloid depolymerisation. J Theor Biol. 2016 May 21; 397: 68-88.
Chapuis J, Moudjou M, Reine F, Herzog L, Jaumain E, Chapuis C, Quadrio I, Boulliat J, Perret-Liaudet A, Dron M, Laude H, Rezaei H & Beringue V. Emergence of two prion subtypes in ovine PrP transgenic mice infected with human MM2-cortical Creutzfeldt-Jakob disease prions. Acta Neuropathol Commun. 2016 Feb 05; 4: 10.
Torrent J, Lange R, Igel-Egalon A, Beringue V & Rezaei H. Getting to the core of prion superstructural variability. Prion. 2016 10(1): 1-8.
Belondrade M, Nicot S, Beringue V, Coste J, Lehmann S & Bougard D. Rapid and Highly Sensitive Detection of Variant Creutzfeldt-Jakob Disease Abnormal Prion Protein on Steel Surfaces by Protein Misfolding Cyclic Amplification: Application to Prion Decontamination Studies. PLoS One. 2016 11(1): e0146833.
2015
Li Q, Richard C A, Moudjou M & Vidic J. Purification and Refolding to Amyloid Fibrils of (His)6-tagged Recombinant Shadoo Protein Expressed as Inclusion Bodies in E. coli. J Vis Exp. 2015 Dec 19; (106): e53432.
Halliez S, Martin-Lanneree S, Passet B, Hernandez-Rapp J, Castille J, Urien C, Chat S, Laude H, Vilotte J L, Mouillet-Richard S & Beringue V. Prion protein localizes at the ciliary base during neural and cardiovascular development, and its depletion affects alpha-tubulin post-translational modifications. Sci Rep. 2015 Dec 18; 5: 17146.
Khalife M, Reine F, Paquet-Fifield S, Castille J, Herzog L, Vilotte M, Moudjou M, Moazami-Goudarzi K, Makhzami S, Passet B, Andreoletti O, Vilette D, Laude H, Beringue V & Vilotte J L. Mutated but Not Deleted Ovine PrP(C) N-Terminal Polybasic Region Strongly Interferes with Prion Propagation in Transgenic Mice. J Virol. 2015 Nov 25; 90(3): 1638-46.
Torrent J, Lange R & Rezaei H. The Volumetric Diversity of Misfolded Prion Protein Oligomers Revealed by Pressure Dissociation. J Biol Chem. 2015 Aug 14; 290(33): 20417-26.
Sarradin P, Viglietta C, Limouzin C, Andreoletti O, Daniel-Carlier N, Barc C, Leroux-Coyau M, Berthon P, Chapuis J, Rossignol C, Gatti J L, Belghazi M, Labas V, Vilotte J L, Beringue V, Lantier F, Laude H & Houdebine L M. Transgenic Rabbits Expressing Ovine PrP Are Susceptible to Scrapie. PLoS Pathog. 2015 Aug; 11(8): e1005077.
Ciric D, Richard C A, Moudjou M, Chapuis J, Sibille P, Daude N, Westaway D, Adrover M, Beringue V, Martin D & Rezaei H. Interaction between Shadoo and PrP Affects the PrP-Folding Pathway. J Virol. 2015 Jun; 89(12): 6287-93.
Floriot S, Vesque C, Rodriguez S, Bourgain-Guglielmetti F, Karaiskou A, Gautier M, Duchesne A, Barbey S, Fritz S, Vasilescu A, Bertaud M, Moudjou M, Halliez S, Cormier-Daire V, Hokayem J E, Nigg E A, Manciaux L, Guatteo R, Cesbron N, Toutirais G, Eggen A, Schneider-Maunoury S, Boichard D, Sobczak-Thepot J & Schibler L. C-Nap1 mutation affects centriole cohesion and is associated with a Seckel-like syndrome in cattle. Nat Commun. 2015 Apr 23; 6: 6894.
Torrent J, Vilchez-Acosta A, Munoz-Torrero D, Trovaslet M, Nachon F, Chatonnet A, Grznarova K, Acquatella-Tran Van Ba I, Le Goffic R, Herzog L, Beringue V & Rezaei H. Interaction of prion protein with acetylcholinesterase: potential pathobiological implications in prion diseases. Acta Neuropathol Commun. 2015 Apr 03; 3: 18.
Galloux M, Gabiane G, Sourimant J, Richard C A, England P, Moudjou M, Aumont-Nicaise M, Fix J, Rameix-Welti M A & Eleouet J F. Identification and characterization of the binding site of the respiratory syncytial virus phosphoprotein to RNA-free nucleoprotein. J Virol. 2015 Apr; 89(7): 3484-96.
Ciric D & Rezaei H. Biochemical insight into the prion protein family. Front Cell Dev Biol. 2015 3: 5.
2014
Cassard H, Torres J M, Lacroux C, Douet J Y, Benestad S L, Lantier F, Lugan S, Lantier I, Costes P, Aron N, Reine F, Herzog L, Espinosa J C, Beringue V & Andreoletti O. Evidence for zoonotic potential of ovine scrapie prions. Nat Commun. 2014 Dec 16; 5: 5821.
Halliez S, Reine F, Herzog L, Jaumain E, Haik S, Rezaei H, Vilotte J L, Laude H & Beringue V. Accelerated, spleen-based titration of variant Creutzfeldt-Jakob disease infectivity in transgenic mice expressing human prion protein with sensitivity comparable to that of survival time bioassay. J Virol. 2014 Aug; 88(15): 8678-86.
Halliez S, Jaumain E, Huor A, Douet J Y, Lugan S, Cassard H, Lacroux C, Beringue V, Andreoletti O & Vilette D. White blood cell-based detection of asymptomatic scrapie infection by ex vivo assays. PLoS One. 2014 9(8): e104287.
Halliez S, Passet B, Martin-Lanneree S, Hernandez-Rapp J, Laude H, Mouillet-Richard S, Vilotte J L & Beringue V. To develop with or without the prion protein. Front Cell Dev Biol. 2014 2: 58.
Lacroux C, Comoy E, Moudjou M, Perret-Liaudet A, Lugan S, Litaise C, Simmons H, Jas-Duval C, Lantier I, Beringue V, Groschup M, Fichet G, Costes P, Streichenberger N, Lantier F, Deslys J P, Vilette D & Andreoletti O. Preclinical detection of variant CJD and BSE prions in blood. PLoS Pathog. 2014 Jun; 10(6): e1004202.
Bellon A, Comoy E, Simoneau S, Mornac S, Dehen C, Perrin A, Arzel A, Arrabal S, Baron H, Laude H, You B, Deslys J P & Flan B. Decontamination of prions in a plasma product manufacturing environment. Transfusion. 2014 Apr; 54(4): 1028-36.
Makzhami S, Passet B, Halliez S, Castille J, Moazami-Goudarzi K, Duchesne A, Vilotte M, Laude H, Mouillet-Richard S, Beringue V, Vaiman D & Vilotte J L. The prion protein family: a view from the placenta. Front Cell Dev Biol. 2014 2: 35.
2013
Moudjou M, Sibille P, Fichet G, Reine F, Chapuis J, Herzog L, Jaumain E, Laferriere F, Richard C A, Laude H, Andreoletti O, Rezaei H & Beringue V. Highly infectious prions generated by a single round of microplate-based protein misfolding cyclic amplification. MBio. 2013 Dec 31; 5(1): e00829-13.
Laferriere F, Tixador P, Moudjou M, Chapuis J, Sibille P, Herzog L, Reine F, Jaumain E, Laude H, Rezaei H & Beringue V. Quaternary structure of pathological prion protein as a determining factor of strain-specific prion replication dynamics. PLoS Pathog. 2013 9(10): e1003702.
Li Q, Chevalier C, Henry C, Richard C A, Moudjou M & Vidic J. Shadoo binds lipid membranes and undergoes aggregation and fibrillization. Biochem Biophys Res Commun. 2013 Aug 30; 438(3): 519-25.
Oumata N, Nguyen P H, Beringue V, Soubigou F, Pang Y, Desban N, Massacrier C, Morel Y, Paturel C, Contesse M A, Bouaziz S, Sanyal S, Galons H, Blondel M & Voisset C. The toll-like receptor agonist imiquimod is active against prions. PLoS One. 2013 8(8): e72112.
Segarra C, Bougard D, Moudjou M, Laude H, Beringue V & Coste J. Plasminogen-based capture combined with amplification technology for the detection of PrP(TSE) in the pre-clinical phase of infection. PLoS One. 2013 8(7): e69632.
Menon R P, Nethisinghe S, Faggiano S, Vannocci T, Rezaei H, Pemble S, Sweeney M G, Wood N W, Davis M B, Pastore A & Giunti P. The role of interruptions in polyQ in the pathology of SCA1. PLoS Genet. 2013 9(7): e1003648.
Halliez S, Chesnais N, Mallucci G, Vilotte M, Langevin C, Jaumain E, Laude H, Vilotte J L & Beringue V. Targeted knock-down of cellular prion protein expression in myelinating Schwann cells does not alter mouse prion pathogenesis. J Gen Virol. 2013 Jun; 94(Pt 6): 1435-40.
Chakroun N, Fornili A, Prigent S, Kleinjung J, Dreiss C A, Rezaei H & Fraternali F. Decrypting Prion Protein Conversion into a beta-Rich Conformer by Molecular Dynamics. J Chem Theory Comput. 2013 May 14; 9(5): 2455-2465.
Passet B, Halliez S, Beringue V, Laude H & Vilotte J L. The prion protein family: looking outside the central nervous system. Prion. 2013 Mar-Apr; 7(2): 127-30.
Salamat M K, Munoz-Montesino C, Moudjou M, Rezaei H, Laude H, Beringue V & Dron M. Mammalian prions: tolerance to sequence changes-how far? Prion. 2013 Mar-Apr; 7(2): 131-5.
Xiao X, Yuan J, Haik S, Cali I, Zhan Y, Moudjou M, Li B, Laplanche J L, Laude H, Langeveld J, Gambetti P, Kitamoto T, Kong Q, Brandel J P, Cobb B A, Petersen R B & Zou W Q. Glycoform-selective prion formation in sporadic and familial forms of prion disease. PLoS One. 2013 8(3): e58786.
Cavaliere P, Pagano B, Granata V, Prigent S, Rezaei H, Giancola C & Zagari A. Cross-talk between prion protein and quadruplex-forming nucleic acids: a dynamic complex formation. Nucleic Acids Res. 2013 Jan 07; 41(1): 327-39.
Cavaliere P, Torrent J, Prigent S, Granata V, Pauwels K, Pastore A, Rezaei H & Zagari A. Binding of methylene blue to a surface cleft inhibits the oligomerization and fibrillization of prion protein. Biochim Biophys Acta. 2013 Jan; 1832(1): 20-8.
2012
Peoc'h K, Levavasseur E, Delmont E, De Simone A, Laffont-Proust I, Privat N, Chebaro Y, Chapuis C, Bedoucha P, Brandel JP, Laquerriere A, Kemeny JL, Hauw JJ, Borg M, Rezaei H, Derreumaux P, Laplanche JL, Haïk S. Substitutions at residue 211 in the prion protein drive a switch between CJD and GSS syndrome, a new mechanism governing inherited neurodegenerative disorders. Hum Mol Genet. 2012 Dec 15;21(26):5417-28. Epub 2012 Sep 10.
Prigent S, Ballesta A, Charles F, Lenuzza N, Gabriel P, Tine LM, Rezaei H, Doumic M. An efficient kinetic model for assemblies of amyloid fibrils and its application to polyglutamine aggregation. PLoS One. 2012;7(11):e43273. Epub 2012 Nov 13.
Cronier S, Carimalo J, Schaeffer B, Jaumain E, Béringue V, Miquel MC, Laude H, Peyrin JM. Endogenous prion protein conversion is required for prion-induced neuritic alterations and neuronal death. FASEB J. 2012 Sep;26(9):3854-61. Epub 2012 Jun 1.
Passet B, Young R, Makhzami S, Vilotte M, Jaffrezic F, Halliez S, Bouet S, Marthey S, Khalifé M, Kanellopoulos-Langevin C, Béringue V, Le Provost F, Laude H, Vilotte JL. Prion protein and Shadoo are involved in overlapping embryonic pathways and trophoblastic development. PLoS One. 2012;7(7):e41959. Epub 2012 Jul 30.
Béringue V, Vilotte JL, Laude H. [Tissue-specific cross-species transmission of prions]. Med Sci (Paris). 2012 Jun-Jul;28(6-7):565-8. Epub 2012 Jul 16.
Salamat K, Moudjou M, Chapuis J, Herzog L, Jaumain E, Béringue V, Rezaei H, Pastore A, Laude H, Dron M. Integrity of helix 2-helix 3 domain of the PrP protein is not mandatory for prion replication. J Biol Chem. 2012 Jun 1;287(23):18953-64. Epub 2012 Apr 16.
Beck KE, Sallis RE, Lockey R, Vickery CM, Béringue V, Laude H, Holder TM, Thorne L, Terry LA, Tout AC, Jayasena D, Griffiths PC, Cawthraw S, Ellis R, Balkema-Buschmann A, Groschup MH, Simmons MM, Spiropoulos J. Use of murine bioassay to resolve ovine transmissible spongiform encephalopathy cases showing a bovine spongiform encephalopathy molecular profile. Brain Pathol. 2012 May;22(3):265-79. Epub 2011 Oct 13.
Petit-Paitel A, Ménard B, Guyon A, Béringue V, Nahon JL, Zsürger N, Chabry J. Prion protein is a key determinant of alcohol sensitivity through the modulation of N-methyl-D-aspartate receptor (NMDAR) activity. PLoS One. 2012;7(4):e34691. Epub 2012 Apr 20.
Béringue V, Herzog L, Jaumain E, Reine F, Sibille P, Le Dur A, Vilotte JL, Laude H. Facilitated cross-species transmission of prions in extraneural tissue. Science. 2012 Jan 27;335(6067):472-5.
==> Open access : Abstract Full text PDF
Diribarne M, Mata X, Rivière J, Bouet S, Vaiman A, Chapuis J, Reine F, Fleurot R, Auvinet G, Deretz S, Allain D, Schibler L, Cribiu EP, Guérin G. LIPH Expression in Skin and Hair Follicles of Normal Coat and Rex Rabbits. PLoS One. 2012;7(1):e30073. Epub 2012 Jan 17.
2011
Tarus B, Bakowiez O, Chenavas S, Duchemin L, Estrozi LF, Bourdieu C, Lejal N, Bernard J, Moudjou M, Chevalier C, Delmas B, Ruigrok RW, Di Primo C, Slama-Schwok A. Oligomerization paths of the nucleoprotein of influenza A virus. Biochimie. 2011 Nov 29.
Zou RS, Fujioka H, Guo JP, Xiao X, Shimoji M, Kong C, Chen C, Tasnadi M, Voma C, Yuan J, Moudjou M, Laude H, Petersen RB, Zou WQ. Characterization of spontaneously generated prion-like conformers in cultured cells. Aging (Albany NY). 2011 Oct;3(10):968-84.
Paoletti F, Malerba F, Kelly G, Noinville S, Lamba D, Cattaneo A, Pastore A. Conformational plasticity of proNGF. PLoS One. 2011;6(7):e22615. Epub 2011 Jul 26.
Helassa N, Revault M, Quiquampoix H, Déjardin P, Staunton S, Noinville S. Adsorption on montmorillonite prevents oligomerization of Bt Cry1Aa toxin. J Colloid Interface Sci. 2011 Apr 15;356(2):718-25. Epub 2011 Jan 25.
Janot JM, Boissière M, Thami T, Tronel-Peyroz E, Helassa N, Noinville S, Quiquampoix H, Staunton S, Déjardin P. Adsorption of alexa-labeled Bt toxin on mica, glass, and hydrophobized glass: study by normal scanning confocal fluorescence. Biomacromolecules. 2010 Jun 14;11(6):1661-6.
Young R, Bouet S, Polyte J, Le Guillou S, Passet B, Vilotte M, Castille J, Beringue V, Le Provost F, Laude H, Vilotte JL. Expression of the prion-like protein Shadoo in the developing mouse embryo. Biochem Biophys Res Commun. 2011 Dec 9;416(1-2):184-7.
Xu Z, Adrover M, Pastore A, Prigent S, Mouthon F, Comoy E, Rezaei H, Deslys JP. Mechanistic insights into cellular alteration of prion by poly-D-lysine: the role of H2H3 domain. FASEB J. 2011 Oct;25(10):3426-35.
Xu Z, Prigent S, Deslys JP, Rezaei H. Dual conformation of H2H3 domain of prion protein in mammalian cells. J Biol Chem. 2011 Sep 12.
Prigent S, Rezaei H. PrP assemblies: spotting the responsible regions in prion propagation. Prion. 2011 Apr-Jun;5(2):69-75.
Langevin C, Andréoletti O, Le Dur A, Laude H, Béringue V. Marked influence of the route of infection on prion strain apparent phenotype in a scrapie transgenic mouse model. Neurobiol Dis. 2011 Jan;41(1):219-25.
Andréoletti O, Orge L, Benestad SL, Beringue V, Litaise C, Simon S, Le Dur A, Laude H, Simmons H, Lugan S, Corbière F, Costes P, Morel N, Schelcher F, Lacroux C. Atypical/Nor98 scrapie infectivity in sheep peripheral tissues. PLoS Pathog. 2011 Feb 10;7(2):e1001285.
Padilla D, Béringue V, Espinosa JC, Andreoletti O, Jaumain E, Reine F, Herzog L, Gutierrez-Adan A, Pintado B, Laude H, Torres JM. Sheep and goat BSE propagate more efficiently than cattle BSE in human PrP transgenic mice. PLoS Pathog. 2011 Mar;7(3):e1001319.
Khalifé M, Young R, Passet B, Halliez S, Vilotte M, Jaffrezic F, Marthey S, Béringue V, Vaiman D, Le Provost F, Laude H, Vilotte JL. Transcriptomic analysis brings new insight into the biological role of the prion protein during mouse embryogenesis. PLoS One. 2011;6(8):e23253. Epub 2011 Aug 15.
Ducrot C, Bed'hom B, Béringue V, Coulon JB, Fourichon C, Guérin JL, Krebs S, Rainard P, Schwartz-Cornil I, Torny D, Vayssier-Taussat M, Zientara S, Zundel E, Pineau T. Issues and special features of animal health research. Vet Res. 2011 Aug 24;42(1):96.
Young R, Le Guillou S, Tilly G, Passet B, Vilotte M, Castille J, Beringue V, Le Provost F, Laude H, Vilotte JL. Generation of Sprn-regulated reporter mice reveals gonadic spatial expression of the prion-like protein Shadoo in mice. Biochem Biophys Res Commun. 2011 Sep 9;412(4):752-6.
Martin R, Chantepie S, Chapuis J, Le-Duc A, Maftah A, Papy-Garcia D, Laude H, Petit JM, Gallet PF. Variation in Chst8 gene expression level affects PrP(C) to PrP(Sc) conversion efficiency in prion-infected Mov cells. Biochem Biophys Res Commun. 2011 Oct 1. [Epub ahead of print]
Jacobs JG, Bossers A, Rezaei H, van Keulen LJM, McCutcheon S, Sklaviadis T, Lantier I, Berthon P, Lantier F, van Zijderveld FG, Langeveld JPM. Proteinase K-resistant material in ARR/VRQ sheep brain affected with classical scrapie is composed mainly of VRQ prion protein. J Virol. 2011, 85 (23) : 12537-12546
Salamat MK, Dron M, Chapuis J, Langevin C, Laude H. Prion propagation in cells expressing PrP glycosylation mutants. J Virol. 2011 Apr;85(7):3077-85.
2010
You B, Aubin JT, Le-Hir G, Arzel A, Laude H, Flan B. In vitro infectivity assay for prion titration for application to the evaluation of the prion removal capacity of biological products manufacturing processes. J Virol Methods. 2010 Mar;164(1-2):1-6.
Dron M, Moudjou M, Chapuis J, Salamat MK, Bernard J, Cronier S, Langevin C, Laude H. Endogenous proteolytic cleavage of disease-associated prion protein to produce C2 fragments is strongly cell- and tissue-dependent. J Biol Chem. 2010 Apr 2;285(14):10252-64.
Chadi S, Young R, Le Guillou S, Tilly G, Bitton F, Martin-Magniette ML, Soubigou-Taconnat L, Balzergue S, Vilotte M, Peyre C, Passet B, Béringue V, Renou JP, Le Provost F, Laude H, Vilotte JL. Brain transcriptional stability upon prion protein-encoding gene invalidation in zygotic or adult mouse. BMC Genomics. 2010 Jul 22;11:448.
MOUDJOU.M, ERMONVAL.M, Le phénomène prion, différents aspects d'un nouveau concept en biologie, Virologie 2010, 14(4). Review. French.
Griffiths PC, Spiropoulos J, Lockey R, Tout AC, Jayasena D, Plater JM, Chave A, Green RB, Simonini S, Thorne L, Dexter I, Balkema-Buschmann A, Groschup MH, Béringue V, Le Dur A, Laude H, Hope J. Characterization of atypical scrapie cases from Great Britain in transgenic ovine PrP mice. J Gen Virol. 2010 Aug;91(Pt 8):2132-8. Epub 2010 Apr 14.
Tixador P, Herzog L, Reine F, Jaumain E, Chapuis J, Le Dur A, Laude H, Beringue V. The physical relationship between infectivity and prion protein aggregates is strain-dependent. PLoS Pathog. 2010 Apr 15; 6(4):e1000859.
Neale MH, Mountjoy SJ, Edwards JC, Vilette D, Laude H, Windl O, Saunders GC. Infection of cell lines with experimental and natural ovine scrapie agents. J Virol. 2010 Mar;84(5):2444-52. Epub 2009 Dec 23.
Ducrot C, Bed'Hom B, Beringue V, Coulon JB, Fourichon C, Guérin JL, Krebs S, Rainard P, Sarradin P, Schwartz I, Torny D, Vayssier-Taussat ML, Zientara S, Zundel E. Enjeux et spécificités de la recherche en santé animale. Productions Animales. 2010, 23 (4) : 359-368. French.
LE GOFFIC R, BOUGUYON E, CHEVALIER C, VIDIC J, DA COSTA B, LEYMARIE O, BOURDIEU C, DECAMPS L, DHORNE-POLLET S, DELMAS B. Influenza A virus protein PB1-F2 exacerbates IFN-beta expression of human respiratory epithelial cells. J Immunol. 2010 Oct 15;185(8):4812-23. Epub 2010 Sep 15.
STEUNOU S, CHICH JF, REZAEI H, VIDIC J. Biosensing of lipid-prion interactions: Insights on charge effect, Cu(II)-ions binding and prion oligomerization. Biosens Bioelectron. 2010 Dec 15;26(4):1399-406.
CHAKROUN N, PRIGENT S, DREISS CA, NOINVILLE S, CHAPUIS C, FRATERNALI F, REZAEI H. The oligomerization properties of prion protein are restricted to the H2H3 domain. FASEB J. 2010 Sep;24(9):3222-31.
GALLOUX M, LIBERSOU S, ALVES ID, MARQUANT R, SALGADO GF, REZAEI H, LEPAULT J, DELMAS B, BOUAZIZ S, MORELLET N. NMR structure of a viral peptide inserted in artificial membranes: a view on the early steps of the birnavirus entry process. J Biol Chem. 2010 Jun 18;285(25):19409-21.
ADROVER M, PAUWELS K, PRIGENT S, DE CHIARA C, XU Z, CHAPUIS C, PASTORE A, REZAEI H. Prion fibrillization is mediated by a native structural element that comprises helices H2 and H3. J Biol Chem. 2010 Jul 2;285(27):21004-12.
NOINVILLE S, VIDIC J, DEJARDIN P. Adsorption rate dependence on convection over a large length of a sensor to get adsorption constant and solute diffusion coefficient. Colloids Surf B Biointerfaces. 2010 Mar 1;76(1):112-6.
CHEVALIER C, AL BAZZAL A, VIDIC J, FEVRIER V, BOURDIEU C, BOUGUYON E, LE GOFFIC R, VAUTHEROT JF, BERNARD J, MOUDJOU M, NOINVILLE S, CHICH JF, DA COSTA B, REZAEI H, DELMAS B. PB1-F2 influenza a virus protein adopts a beta-sheet conformation and forms amyloid fibers in membrane environments. J Biol Chem. 2010 Apr 23;285(17):13233-43.
CHICH JF, CHAPUIS C, HENRY C, VIDIC J, REZAEI H, NOINVILLE S. Vesicle permeabilization by purified soluble oligomers of prion protein: a comparative study of the interaction of oligomers and monomers with lipid membranes. J Mol Biol. 2010 Apr 9;397(4):1017-30.
SUGAWARA M, RESENDE J. M, MENDONCA MORALES C, MARQUETTE A, CHICH J.-F, METZ-BOUTIGUE, BECHINGER B., Membrane structure and interactions of human and bovine Catestatin by solution and solid-state NMR spectroscopy, (2010) FASEB J.
2009
Laude H, Beringue V. [Newly discovered forms of prion diseases in ruminants]. Pathol Biol (Paris). 2009 Mar;57(2):117-26. Review. French.
Dron M, Dandoy-Dron F, Farooq Salamat MK, Laude H. Proteasome inhibitors promote the sequestration of PrPSc into aggresomes within the cytosol of prion-infected CAD neuronal cells. J Gen Virol. 2009 Aug;90(Pt 8):2050-60.
TRAN TL, CASTAGNE N, DUBOSCLARD V, NOINVILLE S, KOCH E, MOUDJOU M, HENRY C, BERNARD J, YEO RP, ELEOUET JF. The respiratory syncytial virus M2-1 protein forms tetramers and interacts with RNA and P in a competitive manner. J Virol. 2009 Jul;83(13):6363-74.
LECHAUVE C., REZAEI H., CELIER C., KIGER L., CORRAL-DEBRINSKI M., NOINVILLE S., CHAUVIERRE C., HAMDANE D., PATO C., MARDEN M.C. Neuroglobin and prion cellular localization: investigation of a potential interaction, J. Mol. Biol. 388 (2009) 968-977.
ZHANG D, SHOOSHTARIZADEH P, LAVENYTIE B, COLIN D.A, CHICH J.-F., VIDIC J., DE BARRY J, CHASSEROT-GOLAZ S., DELANADE F, VAN DERSSELAER A., SCHNEIDER F, HELLE K, AUNIS D, PREVOST G., METZ-BOUTIGUE, Two antimicrobial chromogranin A-derived peptides induce calcium entry in human neutrophils by calmodulin-regulated calcium independent phospholipase A2, PLOSone, 4(2009) e450.
METZ-BOUTIGUE M.-H., SHOOSHTARIZADEH P, PREVOST G, CHICH J.-F. Innate immunity and antimicrobial peptides in mammals Curr. Pharmac. Des. (2009)
SHOOSHTARIZADEH P, ZHANG D., SCHNEIDER F, CHICH J.-F., GASNIER C, BRIOLAT J, HAIKEL Y, AUNIS D, M.-H. METZ-BOUTIGUE M.-H.,The antimicrobial peptides derived from chromogranin/secretogranin family, new actors of innate immunity, Regul. Pept. (2009)
Young R, Passet B, Vilotte M, Cribiu EP, Béringue V, Le Provost F, Laude H, Vilotte JL. The prion or the related Shadoo protein is required for early mouse embryogenesis. FEBS Lett. 2009 Oct 6;583(19):3296-300. Epub 2009 Sep 18.
2008
BERINGUE V., LE DUR A., TIXADOR P., REINE F., LEPOURRY L., PERRET-LIAUDET A., HAIK S., VILOTTE J.L., FONTES M., LAUDE H., Prominent and persistent extraneural infection in human PrP transgenic mice infected with variant CJD, PLoS ONE 3 (2008) 1419.
BERINGUE V., VILOTTE J.L., LAUDE H., Prions agent diversity and species barrier, Vet. Res. (2008) 39:47.
Béringue V, Herzog L, Reine F, Le Dur A, Casalone C, Vilotte JL, Laude H. Transmission of atypical bovine prions to mice transgenic for human prion protein. Emerg Infect Dis. 2008 Dec;14(12):1898-901.
TRIBOUILLARD-TANVIER D., BERINGUE V., DESBAN N., GUG F., BACH S., VOISSET C., GALONS H., LAUDE H., VILETTE D., BLONDEL M., Antihypertensive drug guanabenz is active in vivo against both yeast and mammalian prions, PLoS ONE (2008) 3:e1981.
TRIBOUILLARD-TANVIER D., DOS REIS S., GUG F., VOISSET C., BERINGUE V., KIKOVSKA E., TALAREK N. BACH S., HUANG C., DESBAN N., SAUPE S.J., SUPATTAPONE S., THURET J.Y., CHEDIN S., VILETTE D., GALONS H., SANYAL S., BLONDEL M., Protein folding activity of ribosomal RNA is a selective target of two unrelated antiprion drugs, PLoS ONE (2008) 3:e2174.
COURAGEOT M.P., DAUDE N., NONNO R., PAQUET S., DI BARI M.A., LE DUR A., CHAPUIS J., HILL A.F., AGRIMI U., LAUDE H., VILETTE D., A cell line infectible by prion strains from different species, J. Gen. Virol. 89 (2008) 341-347.
GALLOZZI M., BERINGUE V., DECAUNES P., LE DUR A., LE ROUX K., TILLY G., LE GUILLOU S., HERZOG L., PEYRE C., LADROUE A., CHAPUIS J., VILOTTE M., PASSET B., COSTA J., CHENAIS N., LE PROVOST F, LAUDE H, VILOTTE JL. Spatial and temporal down-regulation of transgene expression using the TRSID-silencer in mice: application to Prnp, FEBS Lett. (2008) 582:2219-24.
GALLOZZI M., CHAPUIS J., LE PROVOST F., LE DUR A., MORGENTHALER C., PEYRE C., DANIEL-CARLIER N., PAILHOUX E., VILOTTE M., PASSET B., HERZOG L., BERINGUE V., COSTA J., TIXADOR P., TILLY G., LAUDE H., VILOTTE J.L., Prnp knockdown in transgenic mice using RNA interference, Transgenic. Res. (2008) Mar 19.
KLIONSKY D.J., ABELIOVICH H., AGOSTINIS P., AGRAWAL D.K., ALIEV G., et al., Guidelines for the use and interpretation of assays for monitoring autophagy in higher eukaryotes, Autophagy (2008) 4:151-175.
MOUILLET-RICHARD S., NISHIDA N., PRADINES E., LAUDE H., SCHNEIDER B., FERAUDET C., GRASSI J., LAUNAY J.M., LEHMANN S., KELLERMANN O., Prions impair bioaminergic functions through serotonin- or catecholamine-derived neurotoxins in neuronal cells, J. Biol. Chem. 2008 Jul 9.
REZAEI H. Prion protein oligomerization. Curr. Alzheimer Res. 5 (2008)572-578.
BENILOVA I., CHEGEL V.I., USHENIN Y.V., VIDIC J., SOLDATKIN A.P., MARTELET C., PAJOT E., JAFFREZIC-RENAULT N., Stimulation of human olfactory receptor 17-40 with odorants probed by surface plasmon resonance., European biophysics journal (2008) 37(6):807-814.
BENILOVA I., MINIC VIDIC J., PAJOT-AUGY E., SOLDATKIN A.P., MARTELET C., JAFFREZIC-RENAULT N., Electrochemical study of human olfactory receptor OR17-40 stimulation by odorants in solution., Materials Science and Engineering (2008) 28:(5-6) 633-639.
CASUSO I., PLA-ROCA M., GOMILA G., MINIC J., PERSUY M.A., SALESSE R., PAJOT-AUGY E., Immobilization of olfactory receptors onto gold electrodes for electrical biosensor., Materials Science and Engineering (2008) 28:(5-6) 686-691.
NOINVILLE S., CHICH J.F., REZAEI H., Misfolding of the prion protein: linking biophysical and biological approaches, Vet. Res. (2008) 39:48.
GAYRARD V., PICARD-HAGEN N., VIGUIE C., JEUNESSE E., TABOURET G., REZAEI H., TOUTAIN P.L., Blood clearance of the prion protein introduced by intravenous route in sheep is influenced by host genetic and physiopathologic factors, Transfusion (2008) 48:609-19.
VIDIC J., GROSCLAUDE J., MONNERIE R., PERSUY M.-A., BADONNEL K., BALY C., CAILLOL M., BRIAND L., SALESSE R., PAJOT-AUGY E., On a Chip Demonstration of a Functional Role for Odorant Binding Protein in the Preservation of Olfactory Receptor Activity at High Odorant Concentration, Lab on a chip (2008) 8(5):678-688.
2007
PAQUET S., DAUDE N., COURAGEOT M.P., CHAPUIS J., LAUDE H., VILETTE D., PrPc does not mediate internalization of PrPSc but is required at an early stage for de novo prion infection of Rov Cells, J. Virol. 81 (2007) 10786-10791.
PAQUET S., LANGEVIN C., CHAPUIS J., JACKSON G.S., LAUDE H., VILETTE D., Efficient dissemination of prions through preferential transmission to nearby cells, J. Gen. Virol. 88 (2007) 706-713.
LA BONNARDIERE C., BONAITI B., ABRIAL D., GASQUI P., CALAVAS D., DUCROT C., BARNOUIN J., Milk yield, age at first calving, and the risk of BSE: an analysis at the farm level in France, Prev. Vet. Med. 78 (2007) 67-78.
JARRIGE N., DUCROT C., CAZEAU G., MORIGNAT E., LA BONNARDIERE C., CALAVAS D., Case-control study on feed risk factors for BSE cases born after the feed ban in France, Vet. Res. 38 (2007) 505-516.
CRONIER S., BERINGUE V., BELLON A., PEYRIN JM., LAUDE H., Prion strain- and species-dependent effects of antiprion molecules in primary neuronal cultures, J. Virol. 81 (2007) 13794-13800.
BERINGUE V., ANDREOLETTI O., LE DUR A., ESSALMANI R., VILOTTE J.L., LACROUX C., REINE F., HERZOG L., BIACABE A.G., BARON T., CARAMELLI M., CASALONE C., LAUDE H., A bovine prion acquires an epidemic bovine spongiform encephalopathy strain-like phenotype on interspecies transmission, The Journal of Neuroscience 27 (2007) 6965– 6971.
MOUDJOU M., BERNARD J., SABUNCU E., LANGEVIN C., LAUDE H., Glycan chains modulate prion protein binding to immobilized metal ions, Neurochem. Int. 50 (2007) 689-695.
CHICH J.-F., DAVID O., VILLERS F., SCHAEFFER B., LUTOMSKI D., HUET S., Statistics for proteomics: experimental design and 2-DE differential analysis, J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 849 (2007) 261-272.
CHICH J.-F., SCHAEFFER B., BOUIN A.-P., MOUTHON F., LABAS V., LARRAMENDY C., DESLYS J.-P., GROSCLAUDE J., Prion infection-impaired functional blocks identified by proteomics enlighten the targets and the curing pathways of an anti-prion drug, Biochim. Biophys. Acta 1774 (2007) 154-167.
2006
TRIBOUILLARD D., BACH S., GUG F., DESBAN N., BERINGUE V., ANDRIEU T., DORMONT D., GALONS H., LAUDE H., VILETTE D., BLONDEL M ., Using budding yeast to screen for anti-prion drugs, Biotechnol. J. 1 (2006) 58-67.
DANDOY-DRON F., BOGDANOVA A., BERINGUE V., BAILLY Y., TOVEY M.G., LAUDE H., DRON M., Infection by ME7 prion is not modified in transgenic mice expressing the yeast chaperone Hsp104 in neurons, Neurosci. Lett. 405 (2006) 181-185.
DRON M., BAILLY Y., BERINGUE V., HAEBERLE A.M., GRIFFOND B., RISOLD P.Y., TOVEY M.G., LAUDE H., DANDOY-DRON F., SCRG1, a potential marker of autophagy in transmissible spongiform encephalopathies, Autophagy. 2 (2006) 58-60.
BERINGUE V., BENCSIK A., LE DUR A., REINE F., LAI T.L., CHENAIS N., TILLY G., BIACABE A.G., BARON T., VILOTTE J.L., LAUDE H., Isolation from cattle of a prion strain distinct from that causing bovine spongiform encephalopathy, PLoS Pathog. 2 (2006) e112.
DE VENEVELLES P., CHICH J.-F., FAIGLE W., LOMBARD B., LOEW D., PERY P., LABBE M., Study of proteins associated with the Eimeria tenella refractile body by a proteomic approach, Int. J. Parasitol. 36 (2006) 1399-1407.
Picard-Hagen N, Gayrard V, Viguié C, Moudjou M, Imbs C, Toutain PL. Prion protein in the cerebrospinal fluid of healthy and naturally scrapie-affected sheep. J Gen Virol. 2006 Dec;87(Pt 12):3723-7.
2005
Carimalo J, Cronier S, Petit G, Peyrin JM, Boukhtouche F, Arbez N, Lemaigre-Dubreuil Y, Brugg B, Miquel MC. Activation of the JNK-c-Jun pathway during the early phase of neuronal apoptosis induced by PrP106-126 and prion infection. Eur J Neurosci. 2005 May;21(9):2311-9.
Dron M, Bailly Y, Beringue V, Haeberlé AM, Griffond B, Risold PY, Tovey MG, Laude H, Dandoy-Dron F. Scrg1 is induced in TSE and brain injuries, and associated with autophagy. Eur J Neurosci. 2005 Jul;22(1):133-46.
ELOIT M., ADJOU K., COULPIER M., FONTAINE J.J., HAMEL R., LILIN T., MESSIAEN S., ANDREOLETTI O., BARON T., BENCSIK A., BIACABE A.G., BERINGUE V., LAUDE H., LE DUR A., VILOTTE J.L., COMOY E., DESLYS J.P., GRASSI J., SIMON S., LANTIER F., SARRADIN P., BSE agent signatures in a goat, Vet. Rec. 156 (2005) 523-524. Erratum in: Vet. Rec. 156 (2005) 620.
LA BONNARDIERE C., DUCROT C., Point de vue épidémiologique sur l'encéphalopathie spongiforme bovine au Royaume Uni et en France, Virologie 9 (2005) 301-314.
LE DUR A., BERINGUE V., ANDREOLETTI O., REINE F., LAI T.L., BARON T., BRATBERG B., VILOTTE J.L., SARRADIN P., BENESTAD S.L., LAUDE H., A newly identified type of scrapie agent can naturally infect sheep with resistant PrP genotypes, Proc. Natl. Acad. Sci. USA 102 (2005) 16031-16036.
ETESSAMI R., CHAUMONTET C., LAUDE H., VILETTE D., Scratch-wounding renders cultivated cells less permissive to prion infection, Biochem. Biophys. Res. Commun. 330 (2005) 5-10.
FEVRIER B., VILETTE D., LAUDE H., RAPOSO G., Exosomes: a bubble ride for prions?, Traffic 6 (2005) 10-17.
SABUNCU E., PAQUET S., CHAPUIS J., MOUDJOU M., LAI T.L., GRASSI J., BARON U., LAUDE H., VILETTE D., Prion proteins from susceptible and resistant sheep exhibit some distinct cell biological features, Biochem. Biophys. Res. Commun. 337 (2005) 791-798 .
DOMINGO N., MASTELLONE I., GRES S., MARIN V., LOREC A.M., TOSINI F., GROSCLAUDE J., FARNARIER C., CHANUSSOT F., The endothelial cholesterol efflux is promoted by the high-density lipoprotein anionic peptide factor, Metabolism 54 (2005) 1087-94.
MINIC J., GROSCLAUDE J., AIOUN J., PERSUY M.A., GOROJANKINA T., SALESSE R., PAJOT-AUGY E., HOU Y., HELALI S., JAFFREZIC-RENAULT N., BESSUEILLE F., ERRACHID A., GOMILA G., RUIZ O., SAMITIER J., Immobilization of native membrane-bound rhodopsin on biosensor surfaces, Biochim. Biophys. Acta. 724 (2005) 324-332.
NIV-SPECTOR L., RAVER N., FRIEDMAN-EINAT M., GROSCLAUDE J., GUSSAKOWSKY E.E., LIVNAH O., GERTLER A., Mapping leptin-interacting sites in recombinant leptin-binding domain (LBD) subcloned from chicken leptin receptor, Biochem. J. 390 (2005) 475-484.
REZAEI H., EGHIAIAN F., PEREZ J., DOUBLET B., CHOISET Y., HAERTLE T., GROSCLAUDE J., Sequential generation of two structurally distinct ovine prion protein soluble oligomers displaying different biochemical reactivities, J. Mol. Biol. 347 (2005) 665-679.
RIGOLET P., XI X.G., RETY S., CHICH J.F., The structural comparison of the bacterial PepX and human DPP-IV reveals sites for the design of inhibitors of PepX activity, FEBS J. 272 (2005) 2050-2059.
VASINA E.N., DEJARDIN P., REZAEI H., GROSCLAUDE J., QUIQUAMPOIX H., Fate of prions in soil: adsorption kinetics of recombinant unglycosylated ovine prion protein onto mica in laminar flow conditions and subsequent desorption, Biomacromolecules 6 (2005) 3425-3432.
REZAEI H., GROSCLAUDE J., HAERTLE T., MARDEN M. , KNOSSOW M., EGHIAIAN F., DEBEY P., Lien entre type génétique et résistance des ovins à la Tremblante : une approche structurale et physico-chimique, Productions Animales (2005) Numéro hors série pp. 45-50.
2004
ANDREOLETTI O., SIMON S., LACROUX C., MOREL N., TABOURET G., CHABERT A., LUGAN S., CORBIERE F., FERRE P., FOUCRAS G., LAUDE H., EYCHENNE F., GRASSI J., SCHELCHER F., PrPSc accumulation in myocytes from sheep incubating natural scrapie, Nat. Med. 10 (2004) 591-593.
ARCHER F., BACHELIN C., ANDREOLETTI O., BESNARD N., PEROOT G., LANGEVIN C., LE DUR A., VILETTE D., BARON-VAN EVERCOOREN A., VILOTTE J.L., LAUDE H., Cultured peripheral neuroglial cells are highly permissive to sheep prion infection, J. Virol. 78 (2004) 482-490.
BERINGUE V., VILETTE D., MALLINSON G., ARCHER F., KAISAR M., TAYEBI M., JACKSON G.S., CLARKE A.R., LAUDE H., COLLINGE J., HAWKE S., PrPSc binding antibodies are potent inhibitors of prion replication in cell lines,J. Biol. Chem. 2004 May 13.
CRONIER S., LAUDE H., PEYRIN J.M., Prions can infect primary cultured neurons and astrocytes and promote neuronal cell death, Proc. Natl. Acad. Sci. USA 101 (2004) 12271-12276.
FEVRIER B., VILETTE D., ARCHER F., LOEW D., FAIGLE W., VIDAL M., LAUDE H., RAPOSO G., Cells release prions in association with exosomes, Proc. Natl. Acad. Sci. USA 101 (2004) 9683-9688.
LA BONNARDIERE C., CALAVAS D., ABRIAL D., MORIGNAT E., DUCROT C., Estimating the trend of the French BSE epidemic over six birth cohorts through the analysis of abattoir screening in 2001 and 2002, Vet. Res. 35 (2004) 299-308.
PAQUET S., SABUNCU E., DELAUNAY J.L., LAUDE H., VILETTE D., Prion infection of epithelial Rov cells is a polarized event, J. Virol. 78 (2004) 7148-7152.
MOUDJOU M., TREGUER E., REZAEI H., SABUNCU E., NEUENDORF E., GROSCHUP M.H., GROSCLAUDE J., LAUDE H., Glycan-controlled epitopes of prion protein include a major determinant of susceptibility to sheep scrapie, J. Virol. 78 (2004) 9270-9276. Erratum in: J. Virol. 78 (2004) 11449. Neuendorf, Erdi.
MOUDJOU M., SABUNCU E., VILETTE D., LE DUR A., LAUDE H., Approche immunochimique de la structure de la PrPc ovine, Productions Animales (2004) Numéro hors série pp. 51-54.
SARRADIN P., LAUDE H., Diversité des souches d'EST chez les ruminants : bilan, enjeux, perspectives, Productions Animales (2004) Numéro hors série pp. 13-20.
VILETTE D., LAUDE H., Pathogénèse des EST : apport des modèles cellulaires, Productions Animales (2004) Numéro hors série pp. 31-36.
CASTAGNE N., BARBIER A., BERNARD J., REZAEI H., HUET J.C., HENRY C., DA COSTA B., ELEOUET J.F., Biochemical characterization of the respiratory syncytial virus P-P and P-N protein complexes and localization of the P protein oligomerization domain, Journal of General Virology 85 (2004) 1643-1653.
CHICH J.-F., X-pro dipeptidyl-peptidase (Lactococcus & Lactobacillus), in: Barrett A.J., Rawlings N.D., Woessner J.F. (eds.), Handbook of proteolytic enzymes, 2nd edition, Academic Press, 2004, pp. 1934-1935.
DE VENEVELLES P., CHICH J.F., FAIGLE W., LOEW D., LABBE M., GIRARD-MISGUICH F., PERY P.,Towards a reference map of Eimeria tenella sporozoite proteins by two-dimensional electrophoresis and mass spectrometry, Int. J. Parasitol. 34 (2004) 1321-1331.
DUCROT C., CABARET J., TOUZEAU S., ABRIAL D., JACOB C., QUIQUAMPOIX H., GROSCLAUDE J., GRUNER L., Epidémiologie de la tremblante et de l'encéphalopathie spongiforme bovine en France, Productions Animales (2004) Numéro hors série pp. 67-77.
EGHIAIAN F., GROSCLAUDE J., LESCEU S., DEBEY P., DOUBLET B., TREGUER E., REZAEI H., KNOSSOW M., Insight into the PrPC-->PrPSc conversion from the structures of antibody-bound ovine prion scrapie-susceptibility variants, Proc. Natl. Acad. Sci. USA 101 (2004) 10254-10259.
KORNBLATT J.A., MARCHAL S., REZAEI H., BALNY C., Characterization of a complex formed between human plasminogen and recombinant sheep prion: pressure and thermal sensitivity of complex formation, Cell. Mol. Biol. (Noisy-le-grand) 50 (2004) 387-396.
MOUDJOU M., TREGUER E., REZAEI H., SABUNCU E., NEUENDORF E., GROSCHUP M.H., GROSCLAUDE J., LAUDE H., Glycan-controlled epitopes of prion protein include a major determinant of susceptibility to sheep scrapie, J. Virol. 78 (2004) 9270-9276. Erratum in: J. Virol. 78 (2004) 11449. Neuendorf, Erdi
PATO C., CELIER C., REZAEI H., GROSCLAUDE J., MARDEN M.C., Heme as an optical probe of a conformational transition of ovine recPrP, Protein Sci. 13 (2004) 1100-1107.
REZAEI H., Rapid procedure for purification and renaturation of recombinant PrP protein, In: Techniques in Prion Research, Edited by S.G.LEHMANN, J. BIRKHAUSER, 2004, pp. 27-36.
TSIROULNIKOV K., REZAEI H., BONCH-OSMOLOVSKAYA E., NEDKOV P., GOUSTEROVA A., CUEFF V., GODFROY A., BARBIER G., METRO F., CHOBERT J.M., CLAYETTE P., DORMONT D., GROSCLAUDE J., HAERTLE T., Hydrolysis of the amyloid prion protein and nonpathogenic meat and bone meal by anaerobic thermophilic prokaryotes and streptomyces subspecies, J. Agric. Food Chem. 52 (2004) 6353-6360.
TSIROULNIKOV K., REZAEI H., BONCH-OSMOLOVSKAYA E., NEDKOV P., GOUSTEROVA A., CUEFF V., GODFROY A. , BARBIER G., METRO F., CHOBERT J.M., CLAYETTE P., DORMONT D., GROSCLAUDE J., HAERTLE T., Utilisation des microorganismes dans l'hydrolyse des amyloïdes et l'hydrolyse des farines animales, Productions Animales (2004) Numéro hors série pp. 109-116.
2003
TILLY G., CHAPUIS J., VILETTE D., LAUDE H., VILOTTE J.L., Efficient and specific down-regulation of prion protein expression by RNAi, Biochem. Biophys. Res. Commun. 305 (2003) 548-551.
SABUNCU E., PETIT S., LE DUR A., LAN LAI T., VILOTTE J.L., LAUDE H., VILETTE D., PrP polymorphisms tightly control sheep prion replication in cultured cells , J. Virol. 77 (2003) 2696-2700.
KORNBLATT J.A., MARCHAL S., REZAEI H., KORNBLATT M.J., BALNY C., LANGE R., DEBEY M.P., HUI BON HOA G., MARDEN M.C., GROSCLAUDE J., The fate of the prion protein in the prion/plasminogen complex, Biochem. Biophys. Res. Commun. 305(2003) 518-522.
MOROT-GAUDRY-TALARMAIN Y., REZAEI H., GUERMONPREZ L., TREGUER E., GROSCLAUDE J., Selective prion protein binding to synaptic components is modulated by oxidative and nitrosative changes induced by copper(II) and peroxynitrite in cholinergic synaptosomes, unveiling a role for calcineurin B and thioredoxin, J. Neurochem. 87 (2003) 1456-1470.
REZAEI H., CHOISET Y., DEBEY M.P., GROSCLAUDE J., HAERTLE T., Study of stability of variants of ovine prion with different susceptibilities to scrapie, Journal of Thermal Analysis and Calorimetry 71 (2003) 237-247.
STOLTZE L., REZAEI H., JUNG G., GROSCLAUDE J., DEBEY P., SCHILD H., RAMMENSEE H.G., CD4+ T cell-mediated immunity against prion proteins, Cell. Mol. Life Sci. 60 (2003) 629-638.
2002
CHAMPOMIER-VERGES M.C., MAGUIN E., MISTOU M.Y., ANGLADE P., CHICH J.F., Lactic acid bacteria and proteomics: current knowledge and perspectives, J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 771 (2002) 329-342.
NEVEU C., RIAUBLANC A., MIRANDA G., CHICH J.F., MARTIN P., Is the apocrine milk secretion process observed in the goat species rooted in the perturbation of the intracellular transport mechanism induced by defective alleles at the alpha(s1)-Cn locus? Reprod. Nutr. Dev. 42 (2002) 163-172.
REZAEI H., CHOISET Y., EGHIAIAN F., TREGUER E., MENTRE P., DEBEY P., GROSCLAUDE J., HAERTLE T., Amyloidogenic unfolding intermediates differentiate sheep prion protein variants, J. Mol. Biol. 322 (2002) 799-814.
RIGOLET P., MECHIN I. , DELAGE M.M., CHICH J.F., The structural basis for catalysis and specificity of the X-prolyl dipeptidyl aminopeptidase from Lactococcus lactis, Structure (Camb) 10 (2002) 1383-1394.
Gatti JL, Métayer S, Moudjou M, Andréoletti O, Lantier F, Dacheux JL, Sarradin P. Prion protein is secreted in soluble forms in the epididymal fluid and proteolytically processed and transported in seminal plasma. Biol Reprod. 2002 Aug;67(2):393-400.
2001
VILETTE D., MADELEINE M.F., ANDREOLETTI O., VILOTTE J.L., LEHMANN S., LAUDE H.,Ex vivo propagation of infectious sheep scrapie agent in heterologous epithelial cells expressing ovine prion protein, Proc Natl Acad Sci USA 98 (2001) 4055-4059.
VILOTTE J.L., SOULIER S., ESSALMANI R., STINNAKRE M.G., VAIMAN D., LEPOURRY L., COSTA DA SILVA J., BESNARD N., DAWSON M., BUSCHMANN A., GROSCHUP M.H., PETIT S., MADELAINE M.F., RAKATOBE S., LE DUR A., VILETTE D., LAUDE H., Markedly increased susceptibility to natural sheep scrapie of transgenic mice expressing ovine PrP, J Virol 75 (2001) 5977-5984.
MOUDJOU M., FROBERT Y., GRASSI J., LA BONNARDIERE C., Cellular prion protein status in sheep: tissue-specific biochemical signatures, J Gen Virol 82 (2001) 2017-24.
CHICH J.F., A minireview : proteomic analysis, a post-genomic approach, Lait 81 (2001) 13-18.
DAVID K., CARNERO-DIAZ E., LEBLANC N., MONESTIEZ M., GROSCLAUDE J., PERROT-RECHENMANN C., Conformational dynamics underlie the activity of the auxin-binding protein, Nt-abp1, J. Biol. Chem. 276 (2001) 34517-34523.
REMY J.J., NESPOULOUS C., GROSCLAUDE J ., GREBERT D., COUTURE L., PAJOT E., SALESSE R., Purification and structural analysis of a soluble human chorionogonadotropin hormone-receptor complex, J. Biol. Chem. 276 (2001) 1681-1687.
ROUZIC P.L., SANDRA O., GROSCLAUDE J ., RENTIER-DELRUE F., JOLOIS O., TUJAGUE M., PAKDEL F., SANDOWSKI Y., COHEN Y., GERTLER A., PRUNET P., Evidence of rainbow trout prolactin interaction with its receptor through unstable homodimerization, Mol. Cell. Endocrinol. 172 (2001) 105-113.
